MAPT and Alzheimer disease: Tau phosphorylation decreases with aging, but increases significantly in Alzheimer’s disease (AD) [31,32,33,34,35] and chronic traumatic encephalopathy (CTE) due to traumatic brain injury (TBI) [36,37,38,39,40].